Sanjeeb Mukherjee And Sushmi Dey

Stories by Sanjeeb Mukherjee And Sushmi Dey

Monsoon makes slow march

Monsoon makes slow march

Rediff.com   16 Jun 2014

Monsoon is expected to cover central and eastern India after Tuesday.

Poor monsoon? Govt may import pulses to beat shortage

Poor monsoon? Govt may import pulses to beat shortage

Rediff.com   11 Jun 2014

The prices of oilseed, coarse cereals & vegetables could also be affected.

Drug makers seek out-of-court settlement in clinical trial cases

Drug makers seek out-of-court settlement in clinical trial cases

Rediff.com   10 Jun 2014

In a letter to health minister Harsh Vardhan, the Indian Pharmaceutical Alliance, an industry body representing leading pharma companies, including Sun Pharma, Lupin, Dr Reddy's Labs, Cadila Health and Glenmark, stressed the need for an out-of-court settlement with health activists fighting for the rights of clinical trial participants.

Drug makers told to give pricing details in 10 days

Drug makers told to give pricing details in 10 days

Rediff.com   6 Jun 2014

The Drug (Prices Control) Order implemented in May last year brought into its purview 652 packs of 348 formulations.

Now, buy medicines and stents on EMI

Now, buy medicines and stents on EMI

Rediff.com   5 Jun 2014

The company did not respond to specific queries on the project's expansion.

PlanCom struggles with the big picture

PlanCom struggles with the big picture

Rediff.com   15 May 2014

Since 2004, Montek Singh Ahluwalia, one of the commission's longest serving deputy chairmen, has been trying to mould it to fit into the new economic order, without much to show for his efforts.

Indian drug cos to benefit as US expedites generic clearances

Indian drug cos to benefit as US expedites generic clearances

Rediff.com   12 May 2014

Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.

Novartis-Glaxo deal signals pharma firms don't have it easy

Novartis-Glaxo deal signals pharma firms don't have it easy

Rediff.com   24 Apr 2014

Experts say despite it being a global deal, the transaction will have to undergo CCI scrutiny because of the scale of operations.

Novartis-GSK-Eli Lilly deal may affect Indian market

Novartis-GSK-Eli Lilly deal may affect Indian market

Rediff.com   23 Apr 2014

On Tuesday, Novartis agreed to buy GSK's oncology products business for $14.5 billion, while selling its vaccines business, excluding flu, to GSK for $7.1 billion.

ICAI to ban three auditors in Satyam case

ICAI to ban three auditors in Satyam case

Rediff.com   23 Apr 2014

ICAI has also imposed a fine of Rs 5 lakh on each of the three accused in Satyam case.

Ranbaxy buy in line with Sun's strategy

Ranbaxy buy in line with Sun's strategy

Rediff.com   17 Apr 2014

The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.

New WPI to have bigger food basket

New WPI to have bigger food basket

Rediff.com   14 Apr 2014

Will give truer reflection on price movements of food products, impact of cereal procurement prices.

Perils of climate change: Wheat growth in UP, Punjab may fall

Perils of climate change: Wheat growth in UP, Punjab may fall

Rediff.com   1 Apr 2014

Climate change can impact the amount and quality of livestock produce,says a report released by inter-governmental panel.

Regulatory pain for GSK's Crocin Advance

Regulatory pain for GSK's Crocin Advance

Rediff.com   28 Mar 2014

The NPPA letter was issued to GSK on Wednesday.

Consumers may have to pay more for insulin

Consumers may have to pay more for insulin

Rediff.com   21 Mar 2014

Apart from Wockhardt, only Biocon manufactures insulin analog indigenously.

24 private hospitals get showcause notices

24 private hospitals get showcause notices

Rediff.com   20 Mar 2014

What started as a mere payment delay seems to have grown into a tussle between the government and leading private hospitals, empanelled under the Central Government Health Scheme.

Why is Novartis likely to lose Tiamulin drug licence?

Why is Novartis likely to lose Tiamulin drug licence?

Rediff.com   19 Mar 2014

Legal experts and official sources said the alleged submission of fake documents can also lead to criminal charges against Novartis.

US regulator urges USV to probe staff for inaccurate data reporting

US regulator urges USV to probe staff for inaccurate data reporting

Rediff.com   5 Mar 2014

The US Food and Drug Administration has asked USV to probe employees who might have been responsible for inaccurate data reporting.

States want Centre to share burden from 7th pay panel

States want Centre to share burden from 7th pay panel

Rediff.com   4 Mar 2014

State governments want the Centre to direct the 14th Finance Commission to compensate states for implementing pay scales, to be recommended by the pay panel.

Why is DLF again under competition watchdog's scanner?

Why is DLF again under competition watchdog's scanner?

Rediff.com   4 Mar 2014

CCI has accused realty player DLF of preparing one-sided agreement with home buyers